日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-Driven Small Cell Lung Cancer.

HDAC抑制剂可激活肿瘤可塑性,增强Myc驱动的小细胞肺癌的免疫治疗反应。

Ghafoor Azam, Zhu Linying, Ohler Zoe Weaver, Meskini Rajaa El, Atkinson Devon, Day Amanda, Bassel Laura, Wang Weixin, Ying Haoxuan, Calvo Katherine R, Pongor Lorinc, Pommier Yves, Thomas Anish, Sun Yilun

Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer

作者更正:ATR抑制剂可增强鲁比替定在小细胞肺癌中的疗效

Schultz, Christopher W; Zhang, Yang; Elmeskini, Rajaa; Zimmermann, Astrid; Fu, Haiqing; Murai, Yasuhisa; Wangsa, Darawalee; Kumar, Suresh; Takahashi, Nobuyuki; Atkinson, Devon; Saha, Liton Kumar; Lee, Chien-Fei; Elenbaas, Brian; Desai, Parth; Sebastian, Robin; Sharma, Ajit Kumar; Abel, Melissa; Schroeder, Brett; Krishnamurthy, Manan; Bassel, Laurel L; Kumar, Rajesh; Roper, Nitin; Aladjem, Mirit; Zenke, Frank T; Ohler, Zoe Weaver; Pommier, Yves; Thomas, Anish

Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer.

奥希替尼耐药的 EGFR 驱动型肺癌 PDX 模型中 MET 通路激活的功能异质性

Roper Nitin, El Meskini Rajaa, Maity Tapan, Atkinson Devon, Day Amanda, Pate Nathan, Cultraro Constance M, Pack Svetlana, Zgonc Valerie, Weaver Ohler Zoe, Guha Udayan